Consequently, 45 tumors corresponded to “GBM, IDH-wild type” and 5 tumors were classified as “astrocytoma IDH-mutant” according to the World Health Organization classification of central nervous system tumors in 2021 [20]. This evidence concerns the gene IDH1 and glioblastoma.